(Q28574165)

31 January 2017

title

Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats (English)

1 reference

31 January 2017

1 reference

1 reference

Nobuyuki Yasuda

1

1 reference

31 January 2017

Tadashi Nagakura

2

1 reference

31 January 2017

Kazuto Yamazaki

3

1 reference

31 January 2017

Takashi Inoue

4

1 reference

31 January 2017

Isao Tanaka

5

1 reference

31 January 2017

language of work or name

English

0 references

publication date

31 May 2002

1 reference

31 January 2017

1 reference

31 January 2017

volume

71

1 reference

31 January 2017

issue

2

1 reference

31 January 2017

page(s)

227–238

1 reference

Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

An active-site mutation (Gly633-->Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Glucagon-like peptide-1: a potent regulator of food intake in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

GIP biology and fat metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901637-5

10.1016/S0024-3205(02)01637-5

7 January 2021

Identifiers

DOI

0 references

1 reference